Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Gilead_Sciences
|
| gptkbp:acquisitionYear |
2006
|
| gptkbp:focusesOn |
cystic fibrosis
respiratory diseases |
| gptkbp:foundedBy |
gptkb:Richard_D._Pops
|
| gptkbp:foundedYear |
2001
|
| gptkbp:headquartersLocation |
gptkb:Seattle,_Washington,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Aztreonam_lysine_for_inhalation
|
| gptkbp:bfsParent |
gptkb:Gilead_Sciences
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Corus Pharma
|